이오플로우 Stock: price and insider trades · South Korea

This page follows insider dealings at 이오플로우 as filed with DART (FSS), a company from the Health Care sector. The last twelve months, up to 2 November 2026, brought 15 filings signed by 7 insiders.

Not one open-market sale was filed. On the buying side, 6 insiders reported 7 purchases totalling €42k. No amount is published for 5 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 board members. At €25k, the purchase published on 27 April 2026 by Kimjessejaejin is the largest of the period (0.065% of market cap).

With 15 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. Since 2021, the database holds 40 purchases and 5 sales by insiders of the company.

The last purchase on record was published on 21 September 2026, which is 50 days ago. Filings reach the DART (FSS) feed a median of 6 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.